Treating disorders by application of insulin-like growth factor

US5093317A · kind A · utility

Assignee

• Cephalon LLC · US

Inventors

• Michael E. Lewis · Hartville, US
• James C. Kauer · Hershey, US
• Kevin Smith · Parkesburg, US
• Kathleen V. Callison · Merchantville, US
• Frank Baldino · West Chester, US

Key dates

• Filing date: Jun 5, 1989
• Grant date: Mar 3, 1992
• Expiry date: Jun 5, 2009

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K1/113
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Method of enhancing the survival of neuronal cells, more preferably non-mitotic neuronal cells and/or cholinergic cells in a mammal, which cells are at risk of dying, which method includes administering to the mammal an effective amount of a functional derivative of Insulin-like Growth Factor I or Insulin-like Growth Factor II.